Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1923806
Max Phase: Preclinical
Molecular Formula: C30H39NO11S2
Molecular Weight: 653.77
Molecule Type: Small molecule
Associated Items:
ID: ALA1923806
Max Phase: Preclinical
Molecular Formula: C30H39NO11S2
Molecular Weight: 653.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCSS/C(CCOC(=O)[C@@H](C)c1ccc2cc(OC)ccc2c1)=C(/C)N(C=O)CC(=O)OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C30H39NO11S2/c1-5-43-44-24(10-11-40-29(37)17(2)19-6-7-21-13-22(39-4)9-8-20(21)12-19)18(3)31(16-32)14-25(33)41-15-23-26(34)27(35)28(36)30(38)42-23/h6-9,12-13,16-17,23,26-28,30,34-36,38H,5,10-11,14-15H2,1-4H3/b24-18-/t17-,23+,26+,27-,28+,30-/m0/s1
Standard InChI Key: MJXMHKMRKNVHLP-PQNPZJOASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.77 | Molecular Weight (Monoisotopic): 653.1965 | AlogP: 2.32 | #Rotatable Bonds: 15 |
Polar Surface Area: 172.29 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.30 | CX Basic pKa: | CX LogP: 0.89 | CX LogD: 0.89 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.13 | Np Likeness Score: 0.79 |
1. Fan W, Wu Y, Li XK, Yao N, Li X, Yu YG, Hai L.. (2011) Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen., 46 (9): [PMID:21641697] [10.1016/j.ejmech.2011.05.029] |
Source(1):